Biocompatible and bioactivable terpolymer-lipid-MnO₂ Nanoparticle-based MRI contrast agent for improving tumor detection and delineation.

"data availability data will be made available on request. acknowledgement this work is supported by the project grant (pjt-162301"

"Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

"This work is supported by the 10.13039/501100000024CIHR Project Grant (PJT-162301), 10.13039/501100000038NSERC Equipment grant (EQPEQ 440689-13), and 10.13039/501100004073Killam Research Fellowship from 10.13039/501100000195Canada Council for the Arts (702-18-0051) to XYW, Ontario Graduate Scholarship and Departmental Scholarship to TYY and EP, and 10.13039/501100004489Mitacs Accelerate Fellowship to MA. Special thanks to Dr. David W. Hedley's group for providing the mice with orthotopic PDX pancreatic cancer used in this paper. Tin-Yo C. Yen: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing, Validation, Visualization. Azhar Z. Abbasi: Conceptualization, Data curation, Formal analysis, Methodology, Writing – review & editing, Funding acquisition, Investigation. Chungsheng He: Conceptualization, Data curation, Investigation, Methodology, Writing – review & editing, Funding acquisition. Ho-Yin Lip: Investigation. Elliya Park: Investigation. Mohammad A. Amini: Investigation. Hibret A. Adissu: Investigation, Writing – review & editing. Warren Foltz: Investigation, Writing – review & editing, Formal analysis, Visualization. Andrew M. Rauth: Writing – review & editing. Jeffrey Henderson: Writing – review & editing. Xiao Yu Wu: Conceptualization, Funding acquisition, Writing – review & editing."